VOYA Investment Management
CBIO

VOYA Investment Management’s Crescent Biopharma CBIO Stock Holding History

VOYA Investment Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-611
Closed -$184K – 2845
2021
Q1 		$184K Buy
611
+423
+225% +$152K ﹤0.01% 2563
2020
Q4 		$71K Buy
188
+77
+69% +$27K ﹤0.01% 2623
2020
Q3 		$34K Hold
111
– – ﹤0.01% 2473
2020
Q2 		$42K Sell
111
-74
-40% -$21K ﹤0.01% 2463
2020
Q1 		$42K Hold
185
– – ﹤0.01% 2516
2019
Q4 		$98K Buy
185
+36
+24% +$19.5K ﹤0.01% 2548
2019
Q3 		$64K Hold
149
– – ﹤0.01% 2476
2019
Q2 		$177K Hold
149
– – ﹤0.01% 2333
2019
Q1 		$185K Hold
149
– – ﹤0.01% 2292
2018
Q4 		$141K Buy
149
+22
+17% +$26.5K ﹤0.01% 2323
2018
Q3 		$183K Hold
127
– – ﹤0.01% 2366
2018
Q2 		$205K Buy
+127
New +$218K ﹤0.01% 2350

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's CBIO Position: Q2 2021 in Review

VOYA Investment Management sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 611 shares — an estimated $184K sold.

VOYA Investment Management first reported a position in CBIO in Q2 2018 and held it in 12 quarters. The position peaked at $205K in Q2 2018. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

  • VOYA Investment Management reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 611 Crescent Biopharma shares in Q2 2021, an estimated $184K.
  • VOYA Investment Management first reported a position in Crescent Biopharma in Q2 2018 and held it in 12 quarters.
  • VOYA Investment Management's Crescent Biopharma position peaked at $205K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.